CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2†

Differentiation therapy is an attractive treatment for osteosarcoma (OS). CD99 is a cell surface molecule expressed in mesenchymal stem cells and osteoblasts that is maintained during osteoblast differentiation while lost in OS. Herein, we show that whenever OS cells regain CD99, they become prone t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Bone Miner Res
Main Authors: Sciandra, Marika, Marino, Maria Teresa, Manara, Maria Cristina, Guerzoni, Clara, Grano, Maria, Oranger, Angela, Lucarelli, Enrico, Lollini, Pier-Luigi, Dozza, Barbara, Pratelli, Loredana, Di Renzo, Maria Flavia, Colombo, Mario Paolo, Picci, Piero, Scotlandi, Katia
פורמט: Artigo
שפה:Inglês
יצא לאור: Blackwell Publishing Ltd 2014
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4255300/
https://ncbi.nlm.nih.gov/pubmed/24677094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2141
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים